HSP90AA1 and cancer: Hsp90α has been shown to be overexpressed in many cancers and is associated with malignant cell survival, proliferation and metastasis, making it one of the most important targets for anticancer drug discovery.Hsp90α inhibitors inhibit Hsp90α by inducing degradation of the substrate protein through conformational changes caused by binding to the appropriate regulatory sites.